Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 59-67

  Beyrer, Chris ^a   Artenstein, Andrew W ^b   Rugpao, Sungwal ^b   Stephens, Henry ^b   VanCott, Thomas C ^b   Robb, Merlin L ^b   Rinkaew, Maneerat ^b   Birx, Deborah L ^b   Khamboonruang, Chirasak ^b   Zimmerman, Peter A ^b   Nelson, Kenrad E ^b   Natpratan, Chawalit ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; DNA; GLYCOPROTEIN GP 160; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONDOM; CONTROLLED STUDY; FEMALE; GENOTYPE; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; MONONUCLEAR CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTITUTION; SEXUALLY TRANSMITTED DISEASE; THAILAND;

ADOLESCENT; ADULT; BODY FLUIDS; CASE-CONTROL STUDIES; CERVIX UTERI; COHORT STUDIES; FEMALE; GENES, MHC CLASS I; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP160; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; PROSTITUTION; SEROEPIDEMIOLOGIC STUDIES; THAILAND; VAGINA;

EID: 0032906032     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314556     Document Type: Article

References (70)

1. Dalgleish AG, Beverley, PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-7.
2. Klatzmann D, Champagne E, Chamaret S, et al. T lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984;312:767-8.
3. McDougal JS, Mawle A, Cort SP, et al. Cellular tropism of the human retrovirus HTLVIII/LAV: I. Role of T cell activation and expression of the T4 antigen. J Immunol 1985;135:3151-62.
4. + T cell by a complex of the 110K viral protein and the T4 molecule. Science 1986;231:382-5.
5. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47:333-48.
6. + T cells. Science 1995;270:1811-5.
7. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor functional cDNA cloning of a seven-transmembrane, G protein coupled receptor. Science 1996;272:872-7.
8. Deng H, Liu R, Ellmeier W, Choe S, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
9. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
10. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
11. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the B-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
12. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage tropic HIV-1. Science 1996;272:1955-8.
13. Alkhatib G, Laio F, Berger EA, Farber JM. A new SIV co-receptor STRL33. Nature 1997;388:238.
14. Deng HK, Unutmaz D, KewalRanani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388:296-300.
15. Pal R, Garzino-Demo A, Markham PD, et al. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science 1997;278:695-8.
16. Connor RI, Ho DD. Transmission and pathogenesis of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994;10:321-3.
17. + T-cell lines and primary macrophages. Proc Natl Acad Sci USA 1995;92:904-8.
18. Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nature Med 1996;2:1244-7.
19. Shearer GM, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996;17:21-4.
20. Just JJ. Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literature examining associations with HLA. Hum Immunol 1995;44:156-69.
21. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med 1996;2:405-11.
22. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
23. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
24. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
25. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-3
26. Zimmerman PA, Buckler-White A, Alkhatib G, et al. An inactivating mutation in the gene encoding CC chemokine receptor 5: impact on HIV-1 susceptibility and disease progression. Mol Med 1997;3:23-36.
27. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997;3:338-40.
28. Quillent C, Oberlin E, Braun J, et al. HIV-1 resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998;351:14-8.
29. Smith MW, Dean M, Carrington M, et al. CCR2 chemokine receptor and AIDS progression. Nature Med 1997;3:1052-3.
30. Michael NL, Louie LG, Rohrbaugh AL, et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nature Med 1997;3:1160-2.
31. Rowland-Jones S, Sutton J, Ariyoshi K, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med 1995;1:59-64.
32. Plummer FA, Fowke K, Nagelkerke NJD, et al. Resistance to HIV among continuously exposed prostitutes in Nairobi [abstract WS-AO7-3]. In: Program and abstracts: IX International Conference on AIDS/IV World STD Congress (Berlin). London: Wellcome Foundation, 1993:23.
33. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 1994;93:1293-7.
34. Kelker HC, Seidlin M, Vogler M, Valentine FT. Lymphocytes from some long-term seronegative heterosexual partners of HIV-infected individuals proliferate in response to HIV antigens. AIDS Res Hum Retroviruses 1992;8:1355-9.
35. Ranki A, Mattinen S, Yarchoan R, et al. T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. AIDS 1989;3:63-9.
36. Clerici M, Giorgi JV, Chou CC, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-9.
37. Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nature Med 1997;3:1250-7.
38. Clerici M, Sison AV, Berzofsky JA, et al. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 1993;7:1427-33.
39. De Maria A, Cirillo C, Moretta L. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis 1994;170:1296-9.
40. Rowland-Jones S, Nixon DF, Aldhous MC, et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993;341:860-1.
41. Borkowsky W, Krasinski K, Moore T, Papaevangelou V. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children. AIDS Res Hum Retroviruses 1990;6:673-8.
42. Cheynier R, Langlade-Demoyen P, Blanche S, et al. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 1992;22:2211-7.
43. Clerici M, Levin JM, Kessler HA, et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 1994;271:42-6.
44. Pinto LA, Sullivan J, Berzofsky JA, et al. Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 1995;96:867-76.
45. Barcellini W, Rzzardi GP, Velati C, et al. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users. AIDS 1995;9:691-4.
46. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991;163:233-9.
47. Piot P, Laga M. Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIV. Br Med J 1989;298:623-4.
48. Sawanpanyalert P, Ungchusak K, Thanparsertsuk S, Akarasewi P. Seroconversion rate and risk factors for HIV-1 infection among low class female sex workers in Chiang Mai, Thailand. AIDS 1994;8:825-9.
49. Division of Communicable Disease Control. HIV/AIDS surveillance data, 1989-1995. Bangkok: Royal Thai Ministry of Public Health, 1996
50. Chandanayingyong D, Stephens HAF, Klaythong R, et al. HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais. Hum Immunol 1997;53:174-82.
51. Imanishi T, Akaza T, Kimura A, Tokunaga D, Gojobori T. W15.1: allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol 1. Oxford, UK: Oxford University Press, 1992:1065-220.
52. Oh S, Fleishlauer K, Yang SY. Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing. Tissue Antigens 1993;41:135-42.
53. Yoshida M, Kimura A, Numano F, et al. Polymerase-chain-based analysis of polymorphism in the HLA-B gene. Hum Immunol 1992;34:257-66.
54. Grenier J, Schleiermacher E, Smith T, et al. The HLA system and leprosy in Thailand. Hum Genet 1978;42:201-13.
55. Clayton J, Lonjou C, Whittle D. Allele and haplotype frequencies for HLA loci in various ethnic groups. In: Charron D, ed. Genetic diversity of HLA. Functional and medical implications. Proceedings of the 12th International Histocompatibility Workshop and Conference. Vol 1. Paris: EDK Medical and Scientific Publishers, 1997:665-820.
56. Vahey M, Wong MT. A quantitative liquid hybridization polymerase chain reaction methodology employing storage phosphor technology. In: Diffenbach CW, Dveksler GS, ed. The Cold Spring Harbor laboratory manual for PCR. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1995:313-38.
57. Vahey M, Wong MT, Michael NL. A standard PCR protocol: rapid isolation of DNA and PCR assay for beta-globin. In: Diffenbach CW, Dveksler GS, ed. The Cold Spring Harbor laboratory manual for PCR. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1995:17-22.
58. Lin J, Myers B, Yen-Lieberman B, et al. Multicenter evaluation of methods for the quantitation of plasma HIV type 1 RNA. J Infect Dis 1994;170:553-62.
59. Yen-Lieberman B, Brambilla D, Jackson B, et al. Evaluation of a quality assurance program for detection of HIV type 1 plasma RNA by the AIDS clinical trials group virology laboratories. J Clin Microbiol 1996;34:2695-701.
60. Artenstein A, VanCott TC, Sitz KV, et al. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J Infect Dis 1997;175:265-71.
61. Belec L, Dupre T, Prazuck T, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995;172:691-7.
62. Biti R, Ffrench R, Young J, Bennetts B, Stewart G, Liang T. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature Med 1997;3:252-3.
63. O'Brien TJ, Winkler C, Dean M, et al. HIV-1 infection in a man homozygous for CCR5Δ32. Lancet 1997;349:1219.
64. Theodora I, Meyer L, Magierowska M, Katlama C, Rouzioux C, Seroco Study Group. HIV-1 infection in an individual homozygous for CCR5Δ32. Lancet 1997;349:1219-20.
65. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet 1997;16:100-3.
66. Ansari-Lari MA, Liu XM, Metzker ML, Rut AR, Gibbs RA. The extent of genetic variation in the CCR5 gene. Nature Genet 1997;16:221-2.
67. Carrington M, Kissner T, Gerrard B, Ivanov S, O'Brien SJ, Dean M. Novel alleles of the chemokine receptor gene CCR5. Am J Hum Genet 1997;61:1261-7.
68. Israel ZR, Marx PA. Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees. J Med Primatol 1995;24:53-60.
69. Miller CJ, Kang DW, Marthas M, et al. Genital secretory immune response to chronic simian immunodeficiency virus (SIV) infection: a comparison between intravenously and genitally inoculated rhesus macaques. Clin Exp Immunol 1992;88:520-6.
70. Miller CJ, McChesney MB, Lu X. Mucosal immune responses to SIV infection. Semin Virol 1996;7:139-45.